Delivery Order SPE2DB20D1100-SPE2DB25FE6Z3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,724.21 on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pens. The contract is firm fixed price with no set-aside designation and requires completion by September 10, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $13,018.75 under a firm fixed-price contract. The delivery order, which concludes on September 11, 2025, represents a competitively awarded non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,285.02 to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Dupixent 300 mg/2 mL pens. This competitive, firm fixed-price delivery order is scheduled for completion by July 16, 2025, with performance fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a single-unit procurement of this specialty pharmaceutical product, which is utilized across military and federal healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dupixent 300 mg/2 ml pens with a ceiling value of $6,887.75. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $18,415.47 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a direct delivery of pharmaceutical products to support federal healthcare operations. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $11,758.26. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 ml pens with a ceiling value of $17,050.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $35,006.30 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 200 mg/1.14 mL pens valued at $6,788.48. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 10, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various...
- The Defense Logistics Agency awarded a delivery order valued at $47,262.06 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dupixent 300 mg/2 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete openly for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6Z3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,059.35 on September 15, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open procurement. The contract is set to be completed by September 16, 2025, and performance will occur at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is one of the nation's major pharmaceutical distributors and a critical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/15/25 |